XTAE
AMDA
Market cap15mUSD
Oct 14, Last price
244.00ILS
Name
Almeda Ventures LP
Chart & performance
P/E
—
P/S
—
EPS
0.10
Vol. 1Y
—
Shs. 5Y
43.36%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
24.72%
Revenues
88k
P
Net income
2m
P
CFO
-1m
L-2.28%
Dividend
Aug 26, 202630.4191 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Almeda Ventures Limited Partnership, established in Tel Aviv, Israel, in 2020, functions as a venture capital firm. The partnership strategically deploys capital across various development stages, including seed, startup, early-stage, and established middle-market companies. Its core investment thesis centers on health technology innovation, with a particular emphasis on medical devices, digital health solutions, bio-convergence, and public R&D collaborations. Additionally, Almeda Ventures allocates funds to life sciences research and development enterprises. Geographically, the firm primarily focuses its investments within Israel, the United States, and Europe.
Key people
Irit Yaniv
Chief Executive Officer, Founding Partner, Director
Amir Blatt
Founding Partner, Chief Information Officer, Director
Yaron Hermeche
Chief Financial Officer
Dean Dudkiewicz
Analyst
Itamar Tzadok
Medical Analyst
Ari Bronshtein
Chairman of the Board
Gilad Glick
Director
Jonathan Halevy
Director
Idan Nurik
Director
External Director
Tzahi Sultan
Founding Partner, Director
Ofra Yamin
External Director
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |